Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (8)

2024

  1. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant

    Australasian Journal of Dermatology, Vol. 64, Núm. 2, pp. 260-267

2022

  1. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome

    Journal of Clinical Immunology, Vol. 42, Núm. 7, pp. 1421-1432

  2. Correction to: Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome (Journal of Clinical Immunology, (2022), 42, 7, (1421-1432), 10.1007/s10875-022-01298-2)

    Journal of Clinical Immunology

  3. First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism

    Arthritis and Rheumatology, Vol. 74, Núm. 4, pp. 692-699

2020

  1. Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation

    Cell Reports, Vol. 32, Núm. 1

  2. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

  3. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

    Journal of Clinical Immunology, Vol. 40, Núm. 7, pp. 987-1000